Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Clinical trial NCT00134719 · COMPLETED

Trial details

NCT number: NCT00134719
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neisseria Meningitidis Haemophilus Influenzae Type b

Start date: 2005-04-11
Primary completion: 2006-07-24
Enrollment: 1104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.